These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 38239974)
21. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1. Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T; Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645 [TBL] [Abstract][Full Text] [Related]
22. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen. Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499 [TBL] [Abstract][Full Text] [Related]
23. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues. Peters PJ; Dueñas-Decamp MJ; Sullivan WM; Clapham PR J Neuroimmune Pharmacol; 2007 Mar; 2(1):32-41. PubMed ID: 18040824 [TBL] [Abstract][Full Text] [Related]
24. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission. Briz V; García D; Méndez-Lagares G; Ruiz-Mateos E; de Mulder M; Moreno-Pérez D; Navarro ML; León-Leal JA; de José MI; Ramos JT; Mellado MJ; González-Tomé MI; Leal M; Muñoz-Fernández MA Pediatr Infect Dis J; 2012 Oct; 31(10):1048-52. PubMed ID: 22828644 [TBL] [Abstract][Full Text] [Related]
25. X4-tropic human immunodeficiency virus IIIB utilizes CXCR4 as coreceptor, as distinct from R5X4-tropic viruses. Islam S; Hoque SA; Adnan N; Tanaka A; Jinno-Oue A; Hoshino H Microbiol Immunol; 2013 Jun; 57(6):437-44. PubMed ID: 23773022 [TBL] [Abstract][Full Text] [Related]
26. Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage. Nankya IL; Tebit DM; Abraha A; Kyeyune F; Gibson R; Jegede O; Nickel G; Arts EJ AIDS Res Ther; 2015; 12():34. PubMed ID: 26435727 [TBL] [Abstract][Full Text] [Related]
27. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. Toma J; Whitcomb JM; Petropoulos CJ; Huang W AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728 [TBL] [Abstract][Full Text] [Related]
28. Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4 Gumbs SBH; Stam AJ; Mudrikova T; Schipper PJ; Hoepelman AIM; van Ham PM; Borst AL; Hofstra L; Gharu L; van Wyk S; Wilkinson E; de Witte LD; Wensing AMJ; Nijhuis M J Neurovirol; 2024 Aug; 30(4):380-392. PubMed ID: 38713307 [TBL] [Abstract][Full Text] [Related]
29. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056 [TBL] [Abstract][Full Text] [Related]
30. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals. Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes. Omi K; Shimizu M; Watanabe E; Matsumura J; Takaku C; Shinya E; Takahashi H Immunology; 2014 Apr; 141(4):596-608. PubMed ID: 24266436 [TBL] [Abstract][Full Text] [Related]
32. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989 [TBL] [Abstract][Full Text] [Related]
33. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of macrophage tropic HIV-1. Gorry PR; Churchill M; Crowe SM; Cunningham AL; Gabuzda D Curr HIV Res; 2005 Jan; 3(1):53-60. PubMed ID: 15638723 [TBL] [Abstract][Full Text] [Related]
35. Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting. Marichannegowda MH; Zemil M; Wieczorek L; Sanders-Buell E; Bose M; O'Sullivan AM; King D; Francisco L; Diaz-Mendez F; Setua S; Chomont N; Phanuphak N; Ananworanich J; Hsu D; Vasan S; Michael NL; Eller LA; Tovanabutra S; Tagaya Y; Robb ML; Polonis VR; Song H bioRxiv; 2023 Jan; ():. PubMed ID: 36712089 [TBL] [Abstract][Full Text] [Related]
36. Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children. Sturdevant CB; Dow A; Jabara CB; Joseph SB; Schnell G; Takamune N; Mallewa M; Heyderman RS; Van Rie A; Swanstrom R PLoS Pathog; 2012 Dec; 8(12):e1003094. PubMed ID: 23300446 [TBL] [Abstract][Full Text] [Related]
37. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768 [TBL] [Abstract][Full Text] [Related]